FDA contracts with BioPharma Services to study generic drugs in humans
BioPharma Services USA Inc.
$20 million agreement covers 5 years of testing
BioPharma Services USA Inc. has been awarded a 5-year, $20 million contract with the Food and Drug Administration to conduct studies of generic drugs in humans.
No comments:
Post a Comment